Harvard Bioscience (HBIO) EBT Margin (2010 - 2026)
Harvard Bioscience (HBIO) reported EBT Margin of 15.93% for Q1 2026, up 21734.0% year-over-year from N/an in Q1 2025, and down 18.03% quarter-over-quarter from 13.5% in Q4 2025.
Harvard Bioscience (HBIO) EBT Margin (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of EBT Margin data on file, last reported at 15.93% in Q1 2026.
- EBT Margin for Q1 2026 came in at 15.93%, up 21734.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 11.57% (up 5186.0% YoY), and the FY2025 annual result was 66.3%, down 5391.0% from the prior year.
- EBT Margin fell to 15.93% in Q1 2026 per HBIO's latest filing, from 13.5% in the prior quarter.
- Over five years, EBT Margin peaked at 11.71% in Q2 2022 and troughed at 233.28% in Q1 2025.
- A 5-year average of 21.91% and a median of 11.02% in 2025 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2025 and 2026: EBT Margin plunged 21499 bps in 2025, then jumped 21734 bps in 2026.
- A 5-year view of EBT Margin shows it stood at 3.14% in 2022, then dropped by 25 bps to 3.92% in 2023, then surged by 161 bps to 2.4% in 2024, then tumbled by 662 bps to 13.5% in 2025, then declined by 18 bps to 15.93% in 2026.
- Business Quant data shows HBIO's EBT Margin at 15.93% in Q1 2026, 13.5% in Q4 2025, and 5.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 33.94% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 0.83% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 3.96% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 35.09% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 21.32% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 0.80% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -4.48% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 14.31% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -0.22% |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -15.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.93% |
| Dec 31, 2025 | -13.50% |
| Sep 30, 2025 | -5.51% |
| Jun 30, 2025 | -11.02% |
| Mar 31, 2025 | -233.28% |
| Dec 31, 2024 | 2.40% |
| Sep 30, 2024 | -20.44% |
| Jun 30, 2024 | -14.20% |
| Mar 31, 2024 | -18.29% |
| Dec 31, 2023 | -3.92% |
| Sep 30, 2023 | -2.22% |
| Jun 30, 2023 | -7.30% |
| Mar 31, 2023 | 4.03% |
| Dec 31, 2022 | -3.14% |
| Sep 30, 2022 | -17.42% |
| Jun 30, 2022 | 11.71% |
| Mar 31, 2022 | -24.39% |
| Dec 31, 2021 | 3.42% |
| Sep 30, 2021 | 0.15% |
| Jun 30, 2021 | -2.16% |